In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $13.35 in the prior trading day, Bicara Therapeutics Inc (NASDAQ: BCAX) closed at $12.42, down -6.97%. In other words, the price has decreased by -$6.97 from its previous closing price. On the day, 0.75 million shares were traded. BCAX stock price reached its highest trading level at $14.04 during the session, while it also had its lowest trading level at $12.01.
Ratios:
Our goal is to gain a better understanding of BCAX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.01 and its Current Ratio is at 36.01. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 06, 2025, initiated with a Outperform rating and assigned the stock a target price of $31.
On December 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.
On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $48.Rodman & Renshaw initiated its Buy rating on November 05, 2024, with a $48 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when LARA S. MEISNER bought 79,146 shares for $13.35 per share.
RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares of BCAX for $32,994,000 on Sep 16 ’24. The Director now owns 4,303,418 shares after completing the transaction at $18.00 per share. On Sep 17 ’24, another insider, Flynn James E, who serves as the Possible Members of 10% Group of the company, bought 70,000 shares for $18.00 each. As a result, the insider paid 1,260,000 and bolstered with 897,587 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 675841728 and an Enterprise Value of 155528992.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $11.10. The 50-Day Moving Average of the stock is -7.28%, while the 200-Day Moving Average is calculated to be -32.21%.
Shares Statistics:
The stock has traded on average 501.76K shares per day over the past 3-months and 743040 shares per day over the last 10 days, according to various share statistics. A total of 54.41M shares are outstanding, with a floating share count of 30.89M. Insiders hold about 43.23% of the company’s shares, while institutions hold 55.58% stake in the company. Shares short for BCAX as of 1740700800 were 5607873 with a Short Ratio of 11.18, compared to 1738281600 on 4077688.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
